RNA Dysregulation in Amyotrophic Lateral Sclerosis - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Frontiers in Genetics Year : 2019

RNA Dysregulation in Amyotrophic Lateral Sclerosis


Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease and is characterized by the degeneration of upper and lower motor neurons. It has become increasingly clear that RNA dysregulation is a key contributor to ALS pathogenesis. The major ALS genes SOD1, TARDBP, FUS, and C9orf72 are involved in aspects of RNA metabolism processes such as mRNA transcription, alternative splicing, RNA transport, mRNA stabilization, and miRNA biogenesis. In this review, we highlight the current understanding of RNA dysregulation in ALS pathogenesis involving these major ALS genes and discuss the potential of therapeutic strategies targeting disease RNAs for treating ALS.

Dates and versions

pasteur-02133252 , version 1 (17-05-2019)



Zoe Butti, Shunmoogum Patten. RNA Dysregulation in Amyotrophic Lateral Sclerosis. Frontiers in Genetics, 2019, 9, pp.712. ⟨10.3389/fgene.2018.00712⟩. ⟨pasteur-02133252⟩


23 View
0 Download



Gmail Facebook X LinkedIn More